Abstract:Abstract Abstract 1666 NF-κB activation has been linked to the promotion of an assortment of malignancies. While in vitro studies have supported a tumor-promoting role for NF-κB in leukemias, in vivo evidence has not been collected. NF-κB has also been proposed as a therapeutic target for Philadelphia chromosome-positive leukemias including chronic myeloid leukemia (CML) and B-cell acute lymphoblastic leukemia (B-ALL). In this study, we investigate the role the Nfkb1 gene plays in CML and B-ALL using mouse models for these leukemias induced by the BCR-ABL oncogene. Contrary to conventional thinking, we find a tumor-suppressing role for Nfkb1 in BCR-ABL leukemias. To induced CML, we transduced bone marrow cells from 5-FU-primed wild type or Nfkb1−/− mice with BCR-ABL-GFP retrovirus, followed by transplantation of the transduced cells into lethally irradiated recipient mice. We show that recipients of BCR-ABL-transduced Nfkb1−/− donor cells developed CML more rapidly than the wild type recipients, correlating to elevated percentages (82.3% vs 38.5%) and total numbers of Gr-1+GFP+ cells in peripheral blood of the mice. We next tested whether the loss of Nfkb1 also accelerated B-ALL development under the B-ALL-inducing conditions, and show that recipients of BCR-ABL-transduced Nfkb1−/− donor cells succumbed to B-ALL more quickly than the wild type recipients. These results suggest that Nfkb1 does not stimulate leukemia growth, and instead, it plays a tumor-suppressing role in CML and B-ALL. Because these findings are opposite from what people believe in the field, we confirmed our findings by conducting a rescue experiment. The Nfkb1 gene encodes the p105 protein; roughly half of p105 product is selectively proteolyzed to yield the p50 transcription factor. In this rescue experiment, we transduced Nfkb1−/− donor cells with BCR-ABL alone or BCR-ABL and p50 of Nfkb1 to induce leukemia, and we show that acceleration of leukemia development caused by the Nfkb1 loss is partially reversed by p50. To study the underlying mechanism, we focused on CARD11, because it plays a critical role in mediating NF-κB signaling in lymphocytes. We find that CARD11 expression is induced in myeloid and increased in lymphoid cell lines expressing BCR-ABL. Furthermore, we induced B-ALL using Card1−/− mice. We find that similar to the loss of Nfkb1, the loss of Card11 expression also accelerates the development of B-ALL. To increase human relevance of our findings, we overexpressed p50 in human K562 cells by retroviral transduction with p50-IRES-GFP or empty vector, and find that FACS-sorted p50/GFP K562 cells grow significantly slower than empty vector-transduced cells. These findings support an idea that Nfkb1 signaling suppresses BCR-ABL-induce leukemia at least partially through a CARD11-dependent mechanism. In summary, our results demonstrate that Nfkb1 plays a tumor-suppressing role in BCR-ABL-induced leukemias, arguing that we should be careful when targeting of Nfkb1 in leukemia treatment. Disclosures: No relevant conflicts of interest to declare.

NF-κB is Required for H-ras Oncogene Induced Abnormal Cell Proliferation and Tumorigenesis

Mechanisms of Cytoplasmic β-Catenin Accumulation and Its Involvement in Tumorigenic Activities Mediated by Oncogenic Splicing Variant of the Receptor Originated from Nantes Tyrosine Kinase

The cell biology of ras-induced transformation: insights from studies utilizing an inducible hybrid oncogene system

An NF-κB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice

The Level of Oncogene H-Ras Correlates with Tumorigenicity and Malignancy

Nuclear Factor Of Activated T3 Is A Negative Regulator Of Ras-Jnk1/2-Ap-1 - Induced Cell Transformation

ras oncogene expression determines sensitivity for intercellular induction of apoptosis

Abstract 4416: IKBKE is a key mediator of Ras activation of NF-κB and Ras oncogenic function

Essential Role of p38γ in K-Ras Transformation Independent of Phosphorylation

Ras-dependent apoptosis correlates with persistent activation of stress-activated protein kinases and induction of isoform(s) of Bcl-x

NFAT3, a substrate of JNKs, is a negative regulator of Ras-JNK-induced cell transformation

Attribution of NF-κB Activity to CHUK/IKKα-Involved Carcinogenesis

Ras-Dependent, Ca2+-Stimulated Activation Of Nuclear Factor Of Activated T Cells By A Constitutively Active Cbl Mutant In T Cells

Nfkb1 Plays A Tumor-Suppressing Role in Bcr-Abl-Induced Leukemias

An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death

Ras Effector Pathways Modulate Scatter Factor-Stimulated NF-κB Signaling and Protection Against DNA Damage

Identification and Characterization of RHEBL1 , a Novel Member of Ras Family, which Activates Transcriptional Activities of NF-Kappa B

NF-κB2 P100 is a Pro-Apoptotic Protein with Anti-Oncogenic Function

NPRL2 is required for proliferation of oncogenic Ras-transformed bronchial epithelial cells

Novel Nexus with NFκB, β-catenin, and RB1 empowers PSMD10/Gankyrin to counteract TNF-α induced apoptosis establishing its oncogenic role

Sequential Inductions of the ZEB1 Transcription Factor Caused by Mutation of Rb and then Ras Proteins Are Required for Tumor Initiation and Progression